0001193125-13-026408.txt : 20130128 0001193125-13-026408.hdr.sgml : 20130128 20130128173000 ACCESSION NUMBER: 0001193125-13-026408 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20130128 DATE AS OF CHANGE: 20130128 GROUP MEMBERS: DAVID SCHNELL GROUP MEMBERS: PROSPECT MANAGEMENT CO. II, L.L.C. GROUP MEMBERS: PROSPECT MANAGEMENT CO., L.L.C. GROUP MEMBERS: PROSPECT VENTURE PARTNERS, L.P. GROUP MEMBERS: RUSSELL C. HIRSCH SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INFINITY PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001113148 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330655706 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-60943 FILM NUMBER: 13552821 BUSINESS ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174531000 MAIL ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: INFINITY PHARMACEUTICALS, INC./NEW/ DATE OF NAME CHANGE: 20060913 FORMER COMPANY: FORMER CONFORMED NAME: DISCOVERY PARTNERS INTERNATIONAL INC DATE OF NAME CHANGE: 20000428 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PROSPECT VENTURE PARTNERS II LP CENTRAL INDEX KEY: 0001135669 IRS NUMBER: 770565416 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 435 TASSO ST STREET 2: STE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 6503278800 MAIL ADDRESS: STREET 1: 435 TASSO STREET SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 SC 13G/A 1 d475423dsc13ga.htm SC 13G/A SC 13G/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b) AND (c) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b)

(Amendment No. 1)*

 

 

Infinity Pharmaceuticals, Inc.

(Name of Issuer)

 

 

Common Stock

(Title of Class of Securities)

45665G 30 3

(CUSIP Number)

December 31, 2012

(Date of Event Which Requires Filing of This Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

Page 1 of 11 Pages

CUSIP NO. 45665G 30 3   13 G   Page 2 of 11 Pages

 

  1   

NAMES OF REPORTING PERSONS.

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

Prospect Venture Partners II, L.P.

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨        (b)  x (1)

 

  3  

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware, United States of America

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY EACH REPORTING

PERSON

WITH

    5    

SOLE VOTING POWER

 

0 shares

   6   

SHARED VOTING POWER

 

0 shares of Common Stock

   7   

SOLE DISPOSITIVE POWER

 

0 shares

   8   

SHARED DISPOSITIVE POWER

 

0 shares of Common Stock

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

0 shares of Common Stock

  10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*  ¨

 

  11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

0.0%

  12  

TYPE OF REPORTING PERSON*

 

PN

 

(1) This Amendment No. 1 to the statement on Schedule 13G is filed by Prospect Venture Partners, L.P. (“PVP”), Prospect Venture Partners II, L.P. (“PVP II”), Prospect Management Co., L.L.C. (“PMC”), and Prospect Management Co. II, L.L.C. (“PMC II”), David Schnell (“Schnell”) and Russell C. Hirsch (“Hirsch,” and together with PVP, PVP II, PMC, PMC II and Schnell, collectively, the “Prospect Entities”). The Prospect Entities expressly disclaim status as a “group” for purposes of this Schedule 13G.

 

Page 2 of 11 Pages

CUSIP NO. 45665G 30 3   13 G   Page 3 of 11 Pages

 

  1   

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

Prospect Management Co. II, L.L.C.

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨        (b)  x (1)

 

  3  

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware, United States of America

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY EACH REPORTING

PERSON

WITH

    5    

SOLE VOTING POWER

 

0 shares

   6   

SHARED VOTING POWER

 

0 shares of Common Stock

   7   

SOLE DISPOSITIVE POWER

 

0 shares

   8   

SHARED DISPOSITIVE POWER

 

0 shares of Common Stock

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

0 shares of Common Stock

  10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*  ¨

 

  11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

0.0%

  12  

TYPE OF REPORTING PERSON*

 

OO

 

(1) This Amendment No. 1 to the statement on Schedule 13G is filed by the Prospect Entities. The Prospect Entities expressly disclaim status as a “group” for purposes of this Schedule 13G.

 

Page 3 of 11 Pages

CUSIP NO. 45665G 30 3   13 G   Page 4 of 11 Pages

 

  1   

NAMES OF REPORTING PERSONS.

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

Prospect Venture Partners, L.P.

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨        (b)  x (1)

 

  3  

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware, United States of America

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY EACH REPORTING

PERSON

WITH

    5    

SOLE VOTING POWER

 

0 shares

   6   

SHARED VOTING POWER

 

0 shares of Common Stock

   7   

SOLE DISPOSITIVE POWER

 

0 shares

   8   

SHARED DISPOSITIVE POWER

 

0 shares of Common Stock

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

0 shares of Common Stock

  10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*  ¨

 

  11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

0.0%

  12  

TYPE OF REPORTING PERSON*

 

PN

 

(1) This Amendment No. 1 to the statement on Schedule 13G is filed by the Prospect Entities. The Prospect Entities expressly disclaim status as a “group” for purposes of this Schedule 13G.

 

Page 4 of 11 Pages

CUSIP NO. 45665G 30 3   13 G   Page 5 of 11 Pages

 

  1   

NAMES OF REPORTING PERSONS.

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

Prospect Management Co., L.L.C.

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨        (b)  x (1)

 

  3  

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware, United States of America

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY EACH REPORTING

PERSON

WITH

    5    

SOLE VOTING POWER

 

0 shares

   6   

SHARED VOTING POWER

 

0 shares of Common Stock

   7   

SOLE DISPOSITIVE POWER

 

0 shares

   8   

SHARED DISPOSITIVE POWER

 

0 shares of Common Stock

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

0 shares of Common Stock

  10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*  ¨

 

  11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

0.0%

  12  

TYPE OF REPORTING PERSON*

 

OO

 

(1) This Amendment No. 1 to the statement on Schedule 13G is filed by the Prospect Entities. The Prospect Entities expressly disclaim status as a “group” for purposes of this Schedule 13G.

 

Page 5 of 11 Pages

CUSIP NO. 45665G 30 3   13 G   Page 6 of 11 Pages

 

  1   

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

David Schnell

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨        (b)  x (1)

 

  3  

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States of America

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY EACH REPORTING

PERSON

WITH

    5    

SOLE VOTING POWER

 

0 shares of Common Stock

   6   

SHARED VOTING POWER

 

0 shares of Common Stock

   7   

SOLE DISPOSITIVE POWER

 

0 shares of Common Stock

   8   

SHARED DISPOSITIVE POWER

 

0 shares of Common Stock

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

0 shares of Common Stock

  10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*  ¨

 

  11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

0.0%

  12  

TYPE OF REPORTING PERSON*

 

IN

 

(1) This Amendment No. 1 to the statement on Schedule 13G is filed by the Prospect Entities. The Prospect Entities expressly disclaim status as a “group” for purposes of this Schedule 13G.

 

Page 6 of 11 Pages

CUSIP NO. 45665G 30 3   13 G   Page 7 of 11 Pages

 

  1   

NAMES OF REPORTING PERSONS.

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

Russell C. Hirsch

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨        (b)  x (1)

 

  3  

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware, United States of America

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY EACH REPORTING

PERSON

WITH

    5    

SOLE VOTING POWER

 

0 shares of Common Stock

   6   

SHARED VOTING POWER

 

0 shares of Common Stock

   7   

SOLE DISPOSITIVE POWER

 

0 shares of Common Stock

   8   

SHARED DISPOSITIVE POWER

 

0 shares of Common Stock

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

0 shares of Common Stock

  10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*  ¨

 

  11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

0.0%

  12  

TYPE OF REPORTING PERSON*

 

IN

 

(1) This Amendment No. 1 to the statement on Schedule 13G is filed by the Prospect Entities. The Prospect Entities expressly disclaim status as a “group” for purposes of this Schedule 13G.

 

Page 7 of 11 Pages

Introductory Note: This Amendment No. 1 to the statement on Schedule 13G is filed on behalf of Prospect Venture Partners, L.P., a limited partnership organized under the laws of the State of Delaware (“PVP”), Prospect Venture Partners II, L.P., a limited partnership organized under the laws of the State of Delaware (“PVP II”), Prospect Management Co, L.L.C., a limited liability company organized under the laws of the State of Delaware (“PMC”), Prospect Management Co. II, L.L.C., a limited liability company organized under the laws of the State of Delaware (“PMC II”), David Schnell (“Schnell”) and Russell C. Hirsch (“Hirsch”), in respect of shares of Common Stock of Infinity Pharmaceuticals, Inc.

 

Item 1

 

(a)      Name of Issuer:        Infinity Pharmaceuticals, Inc.   
(b)      Address of Issuer’s Principal Executive Offices:    780 Memorial Drive
           Cambridge, Massachusetts 02139

 

Item 2

 

(a) Name of Person(s) Filing:

Prospect Venture Partners, L.P. (“PVP”)

Prospect Venture Partners II, L.P. (“PVP II”)

Prospect Management Co., L.L.C. (“PMC”)

Prospect Management Co. II, L.L.C. (“PMC II”)

David Schnell (“Schnell”)

Russell C. Hirsch (“Hirsch”)

 

(b)            Address of Principal Business Office:    c/o Prospect Venture Partners
        435 Tasso Street, Suite 200
        Palo Alto, California 94301

 

(c) Citizenship:

 

Entities:    PVP    -    Delaware
   PVP II    -    Delaware
   PMC    -    Delaware
   PMC II    -    Delaware
Individuals:    Schnell    -    United States of America
   Hirsch    -    United States of America

 

(d)            Title of Class of Securities:    Common Stock

 

(e)          CUSIP Number:    45665G 30 3

 

Item 3 Not applicable.

 

Page 8 of 11 Pages

Item 4 Ownership.

The following information with respect to the ownership of the Common Stock of the Issuer by the persons filing this statement on Schedule 13G is provided as of December 31, 2012:

 

Prospect Entities    Shares Held
Directly		      Sole
Voting
Power		      Shared
Voting Power		      Sole
Dispositive
Power		      Shared
Dispositive
Power		      Beneficial
Ownership		      Percentage
of Class		  

Prospect Venture

Partners, L.P.

      0         0         0         0         0         0         0.00 % 

Prospect Venture

Partners II, L.P.

      0         0         0         0         0         0         0.00 % 

Prospect Management

Co., L.L.C. (1)

      0         0         0         0         0         0         0.00 % 

Prospect Management

Co. II, L.L.C. (2)

      0         0         0         0         0         0         0.00 % 

David Schnell (1)(2)

      0         0         0         0         0         0         0.00 % 

Russell C. Hirsch (2)

      0         0         0         0         0         0         0.00 % 

 

(1) Prospect Management Co., L.L.C. (“PMC”) serves as the general partner of Prospect Venture Partners, L.P., and owns no securities of the Issuer directly. Schnell serves as the Managing Director of PMC.
(2) Prospect Management Co. II, L.L.C. (“PMC II”) serves as the general partner of Prospect Venture Partners II, L.P., and owns no securities of the Issuer directly. Schnell and Hirsch serve as Managing Directors of PMC II.

 

Item 5 Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof, the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: x

 

Item 6 Ownership of More Than Five Percent on Behalf of Another Person.

Not applicable.

 

Item 7 Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company.

Not applicable.

 

Item 8 Identification and Classification of Members of the Group.

Not applicable.

 

Item 9 Notice of Dissolution of Group.

Not applicable.

 

Item 10 Certification.

Not applicable.

 

Page 9 of 11 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: January 28, 2013

 

PROSPECT VENTURE PARTNERS, L.P.
By:   Prospect Management Co., L.L.C.
Its:   General Partner

 

/s/ Lori Hoover-Simotas

Lori Hoover-Simotas
Attorney-in-Fact

 

PROSPECT MANAGEMENT CO., L.L.C.

/s/ Lori Hoover-Simotas

Lori Hoover-Simotas

Attorney-in-Fact

 

PROSPECT VENTURE PARTNERS II, L.P.
By:   Prospect Management Co. II, L.L.C.
Its:   General Partner

 

/s/ Lori Hoover-Simotas

Lori Hoover-Simotas
Attorney-in-Fact
PROSPECT MANAGEMENT CO. II, L.L.C.

/s/ Lori Hoover-Simotas

Lori Hoover-Simotas
Attorney-in-Fact

/s/ Lori Hoover-Simotas

Lori Hoover-Simotas
Attorney-in-Fact for David Schnell

/s/ Lori Hoover-Simotas

Lori Hoover-Simotas
Attorney-in-Fact for Russell C. Hirsch

Exhibit(s):        A - Joint Filing Statement

 

Page 10 of 11 Pages

EX-99.1 2 d475423dex991.htm EX-A EX-A

EXHIBIT A

JOINT FILING STATEMENT

We, the undersigned, hereby express our agreement that the attached Schedule 13G (or any amendments thereto) relating to the Common Stock of Infinity Pharmaceuticals, Inc. is filed on behalf of each of us.

Dated: January 28, 2013

 

PROSPECT VENTURE PARTNERS, L.P.

By:   Prospect Management Co., L.L.C.
Its:   General Partner

 

/s/ Lori Hoover-Simotas

Lori Hoover-Simotas

Attorney-in-Fact

 

PROSPECT MANAGEMENT CO., L.L.C.

/s/ Lori Hoover-Simotas

Lori Hoover-Simotas

Attorney-in-Fact

 

PROSPECT VENTURE PARTNERS II, L.P.
By:   Prospect Management Co. II, L.L.C.
Its:   General Partner

 

/s/ Lori Hoover-Simotas

Lori Hoover-Simotas

Attorney-in-Fact

 

PROSPECT MANAGEMENT CO. II, L.L.C.

/s/ Lori Hoover-Simotas

Lori Hoover-Simotas

Attorney-in-Fact

 

/s/ Lori Hoover-Simotas

Lori Hoover-Simotas

Attorney-in-Fact for David Schnell

/s/ Lori Hoover-Simotas

Lori Hoover-Simotas

Attorney-in-Fact for Russell C. Hirsch

 

Page 11 of 11 Pages